Allergy Treatment Drugs Market Analysis | Coherent Market Insights

1. Coherent Market InsightS Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

2. Allergy Treatment Drugs Market (2020-2027) • An allergy is a medical condition where the immune system reacts abnormally when exposed to certain foreign substances. These allergy-producing substances are known as allergens. Allergens can be dust particles, mites, molds, pollens, animal proteins, foods, and medications. • Allergies can be perennial or seasonal. Perennial allergies occur due to specific allergens that cause an allergic reaction throughout the year. Allergens responsible for perennial allergies include pet hair or dander, food, and medication. Seasonal allergies occur due to weather changes that allow growth of mold, insect or grass. Seasonal allergies are caused by airborne allergens such as pollens and ragweed. Symptoms of allergic reactions include itching, runny & blocked nose, watery eyes, wheezing, shortness of breath, swelling in lips, eyes or face, sneezing, and others

3. Global Allergy Treatment Drugs Market – Dynamics • Rising incidence of allergic conjunctivitis and rhinitis is expected to propel growth of the global allergy treatment drugs market over the forecast period. For instance, according to the article published in the Asia Pacific Association of Allergy, Asthma and Clinical Immunology, in April 2019, simple allergic conjunctivitis affects around 10% to 30% of the population globally. Moreover, according to the National Health Interview Survey, 2018, around 19.2 million adults and 5.2 million children were diagnosed with allergic rhinitis in the U.S. in 2017. • Moreover, various mergers, agreements, and acquisitions among key players are expected to drive the growth of allergy treatment drugs market over the forecast period.

4. s For instance, in July 2018, Glenmark Specialty S.A., a division of Glenmark Pharmaceuticals Ltd. (Glenmark), entered into an exclusive licensing agreement with Seqirus Pty. Ltd., to commercialize Ryaltris in Australia and New Zealand. Ryaltris is a nasal spray used for the treatment of symptoms associated with seasonal allergic rhinitis. Furthermore, rising product approvals by the regulatory authorities are expected to propel the growth of allergy treatment market. For instance, in December 2019, Glenmark Pharmaceuticals Ltd., announced that Seqirus Pty. Ltd., received marketing approval from the Therapeutic Goods Administration (TGA), Australia.

5. Global Allergy Treatment Drugs Market – Regional Insights • North America accounted for the largest market share in 2018, owing to rising approval of novel drugs from regulatory bodies in the region. For instance, in January 2020, Aimmune Therapeutics, Inc. received the U.S. Food and Drug Administration (FDA) approval for PALFORZIA, for the treatment of peanut allergy. Moreover, increasing prevalence of various allergies is also expected to propel growth of the allergy treatment drugs market in the region. • For instance, according to the American Academy of Pediatrics (AAP), in 2018, around 5.6 million children had a food allergy in the U.S.

6. Europe is expected to be the second-largest market for global allergy treatment drugs and it is projected to witness significant growth over the forecast period, owing to increasing number of food allergy incidences in the region. For instance, according to the Food Standard Agency (FSA), in March 2017, around 2 million people were diagnosed with food allergy in the U.K.

7. Global Allergy Treatment Drugs Market – Competitive Landscape • Key players operating in the allergy treatment drugs market include Aimmune Therapeutics, Inc., Bayer AG, HAL Allergy B.V., Johnson & Johnson Services, Inc., Magna Pharmaceuticals, Inc., Stallergenes Greer, and others.

8. Global Allergy Treatment Drugs Market – Taxonomy • On the basis of allergy type, the global allergy treatment drugs market is segmented into: • Drug Allergy • Eye Allergy • Food Allergy • Skin Allergy • Allergic Rhinitis • Others

9. On the basis of treatment type, the global allergy treatment drugs market is segmented into: • Anti-allergy Drugs • Antihistamines • Corticosteroid • Decongestants • Others • Immunotherapy • Subcutaneous Immunotherapy (SCIT) • Sublingual Immunotherapy (SLIT)

10. On the basis of dosage form, the global allergy treatment drugs market is segmented into: • Tablets • Inhalers • Nasal Sprays • Eye Drops • Injections • On the basis of distribution channel, the global allergy treatment drugs market is segmented into: • Hospital Pharmacies • Retail Pharmacies

11. Online Pharmacies • On the basis of region, the global allergy treatment drugs market is segmented into: • North America • Latin America • Europe • Asia Pacific • Middle East • Africa

12. Request sample copy here Request PDF brochure here Request Customization here Talk to Analyst Buy Now Reference: https://www.coherentmarketinsights.com/ongoing-insight/allergy-treatment-drugs-market-3499

13. About Us: • Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. • What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

14. Contact Us: • Mr. Shah • Coherent Market Insights Pvt. Ltd. • Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S. • Phone: +1-206-701-6702 • Email :sales@coherentmarketinsights.com

15. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/